Suppr超能文献

内镜黏膜下剥离术治疗早期食管鳞状细胞癌患者:来自一项前瞻性西方系列研究的结果。

Endoscopic submucosal dissection in patients with early esophageal squamous cell carcinoma: results from a prospective Western series.

机构信息

Gastroenterology Department, IRCCS Istituto Clinico Humanitas, Milan, Italy.

出版信息

Gastrointest Endosc. 2010 Apr;71(4):715-21. doi: 10.1016/j.gie.2009.11.020.

Abstract

BACKGROUND

Although endoscopic submucosal dissection (ESD) is becoming accepted as an established treatment for superficial esophageal squamous cell neoplasia, the majority of data on this endoscopic modality has been provided by Japanese series.

OBJECTIVE

To assess the efficacy and safety of ESD for esophageal squamous cell neoplasia in a consecutive series of patients treated in a Western setting.

DESIGN AND SETTING

Single-center, prospective observational study.

PATIENTS AND INTERVENTION

From January 2005 to July 2008, 20 patients with superficial esophageal squamous cell neoplasia were treated by ESD.

MAIN OUTCOME MEASUREMENTS

Rates of en bloc resection, complete resection, and complications were evaluated as short-term outcomes. Overall survival, local or distant recurrence, and postoperative stricture rates were evaluated as long-term outcomes.

RESULTS

ESD was performed in 20 patients (mean age 64 years, range 46-81 years; 16 men). The mean size of the lesion was 32 mm (range 15-60 mm); it was 30 mm or larger in 14 patients (70%). The mean time of ESD was 89 minutes (range 58-180 minutes). En bloc resection with resection-free margins was achieved in 18 patients (90%), whereas 2 patients presented with incomplete or indeterminate resection. Two cases (10%) of mediastinal emphysema without overt perforation and 1 case (5%) of post-ESD symptomatic stricture were reported. No local or distant post-ESD recurrence occurred in those with resection-free margins at a median follow-up of 18 months.

LIMITATIONS

Small number of patients and limited follow-up.

CONCLUSION

This Western series study confirms that ESD is a potentially curative treatment for superficial esophageal squamous cell neoplasia. Early and late complication rates were comparable to those of Japanese series. ESD should be probably considered as the treatment of choice in all large lesions amenable to endoscopic treatment.

摘要

背景

尽管内镜黏膜下剥离术(ESD)已被广泛接受,成为治疗食管浅表鳞状细胞肿瘤的一种标准治疗方法,但关于这种内镜治疗方法的数据主要来自日本的系列研究。

目的

评估 ESD 治疗西方人群中食管浅表鳞状细胞肿瘤的疗效和安全性。

设计和设置

单中心前瞻性观察研究。

患者和干预措施

从 2005 年 1 月至 2008 年 7 月,对 20 例食管浅表鳞状细胞肿瘤患者进行了 ESD 治疗。

主要观察指标

作为短期结果,评估整块切除率、完全切除率和并发症发生率。作为长期结果,评估总生存率、局部或远处复发率和术后狭窄率。

结果

20 例患者(平均年龄 64 岁,范围 46-81 岁;16 例男性)进行了 ESD。病变的平均大小为 32mm(范围 15-60mm);14 例患者(70%)的病变大小为 30mm 或更大。ESD 的平均时间为 89 分钟(范围 58-180 分钟)。18 例患者(90%)实现了整块切除且无切缘残留,而 2 例患者为不完全或不确定的切除。2 例(10%)出现纵隔气肿而无明显穿孔,1 例(5%)出现 ESD 后症状性狭窄。在中位随访 18 个月时,具有无切缘残留的患者无局部或远处 ESD 后复发。

局限性

患者数量少,随访时间有限。

结论

本西方系列研究证实,ESD 是治疗食管浅表鳞状细胞肿瘤的一种潜在根治性治疗方法。早期和晚期并发症发生率与日本系列研究相似。对于所有可进行内镜治疗的大病变,ESD 可能应被视为首选治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验